366 related articles for article (PubMed ID: 31888082)
1. A New Vision of IgA Nephropathy: The Missing Link.
Sallustio F; Curci C; Di Leo V; Gallone A; Pesce F; Gesualdo L
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888082
[TBL] [Abstract][Full Text] [Related]
2. Genetic study of immunoglobulin A nephropathy: From research to clinical application.
Li M; Yu X
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():26-31. PubMed ID: 30298665
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy.
Schena FP; Scivittaro V; Ranieri E; Sinico R; Benuzzi S; Di Cillo M; Aventaggiato L
Clin Exp Immunol; 1993 Apr; 92(1):139-44. PubMed ID: 8467558
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
5. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
6. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
7. The genetics and immunobiology of IgA nephropathy.
Kiryluk K; Novak J
J Clin Invest; 2014 Jun; 124(6):2325-32. PubMed ID: 24892706
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
Sun Q; Zhang J; Zhou N; Liu X; Shen Y
PLoS One; 2015; 10(2):e0112305. PubMed ID: 25647400
[TBL] [Abstract][Full Text] [Related]
10. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
11. In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions.
Tam KY; Leung JC; Chan LY; Lam MF; Tang SC; Lai KN
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F359-68. PubMed ID: 20484297
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
Grossetête B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
[TBL] [Abstract][Full Text] [Related]
13. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
[TBL] [Abstract][Full Text] [Related]
14. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
15. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
16. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
17. In vitro immunoglobulin production in relatives of patients with IgA nephropathy.
Scivittaro V; Ranieri E; Di Cillo M; Aventaggiato L; Emancipator SN; Schena FP
Clin Nephrol; 1994 Jul; 42(1):1-8. PubMed ID: 7923960
[TBL] [Abstract][Full Text] [Related]
18. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
19. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
Coppo R; Amore A; Chiesa M; Lombardo F; Cirina P; Andrulli S; Passerini P; Conti G; Peruzzi L; Giraudi R; Messina M; Segoloni G; Ponticelli C
Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266
[TBL] [Abstract][Full Text] [Related]
20. [IgA nephropathy--IgA1 disease].
Maksić D; Marić M; Mijusković Z; Dimitrijević J; Kovacević Z; Jovanović D
Vojnosanit Pregl; 1996; 53(4):293-6. PubMed ID: 9229944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
